On Monday, Health Catalyst Inc (NASDAQ: HCAT) opened higher 4.80% from the last session, before settling in for the closing price of $8.13. Price fluctuations for HCAT have ranged from $5.42 to $11.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 21.79% over the past five years. Company’s average yearly earnings per share was noted 107.65% at the time writing. With a float of $58.34 million, this company’s outstanding shares have now reached $60.85 million.
Let’s look at the performance matrix of the company that is accounted for 1300 employees. In terms of profitability, gross margin is 35.68%, operating margin of -21.37%, and the pretax margin is -26.25%.
Health Catalyst Inc (HCAT) Insider Updates
A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Health Catalyst Inc is 4.12%, while institutional ownership is 87.51%. The most recent insider transaction that took place on Nov 15 ’24, was worth 11,602. In this transaction Chief People Officer of this company sold 1,365 shares at a rate of $8.50, taking the stock ownership to the 112,910 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Officer proposed sale 1,365 for $8.45, making the entire transaction worth $11,534.
Health Catalyst Inc (HCAT) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 0.02 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.01) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 107.65% per share during the next fiscal year.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Check out the current performance indicators for Health Catalyst Inc (HCAT). In the past quarter, the stock posted a quick ratio of 1.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.40 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Health Catalyst Inc (NASDAQ: HCAT) saw its 5-day average volume 0.5 million, a negative change from its year-to-date volume of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 53.77%. Additionally, its Average True Range was 0.51.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 84.01%, which indicates a significant increase from 71.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.23% in the past 14 days, which was higher than the 79.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.13, while its 200-day Moving Average is $7.34. Nevertheless, the first resistance level for the watch stands at $8.67 in the near term. At $8.82, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.03. If the price goes on to break the first support level at $8.31, it is likely to go to the next support level at $8.09. Assuming the price breaks the second support level, the third support level stands at $7.94.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
There are currently 60,848K shares outstanding in the company with a market cap of 518.42 million. Presently, the company’s annual sales total 295,940 K according to its annual income of -118,150 K. Last quarter, the company’s sales amounted to 76,350 K and its income totaled -14,730 K.
